Literature DB >> 28700204

Effect of Terminal-Group Functionality on the Ability of Dendrimers to Bind Proteins.

Fumiko Chiba1, Lance J Twyman1.   

Abstract

It is known that dendrimers can bind proteins with good selectively. This selectivity comes about from an optimization based on matching the size of the dendrimer with the size of the protein's interfacial binding area. In this paper, we report how this selectivity can be moderated by the functionality on the surface of the dendrimer. Specifically, we describe the synthesis of amino acid functionalized dendrimers and the effect of functionality on the dendrimer's ability to bind and inhibit the enzymatic protein, chymotrypsin. The results show how dendrimer binding can be increased or decreased depending on the terminal functionality. These results will allow new ligands to be designed and synthesized, possessing increased and selective protein-binding abilities.

Mesh:

Substances:

Year:  2017        PMID: 28700204     DOI: 10.1021/acs.bioconjchem.7b00350

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

Review 1.  Nanotechnologies in Pancreatic Cancer Therapy.

Authors:  Ayesha Manzur; Adeolu Oluwasanmi; Darren Moss; Anthony Curtis; Clare Hoskins
Journal:  Pharmaceutics       Date:  2017-09-25       Impact factor: 6.321

2.  Synthesis of Oligomeric and Monomeric Functionalized Graphene Oxides and a Comparison of Their Abilities to Perform as Protein Ligands and Enzyme Inhibitors.

Authors:  Azrah Abdul Aziz; Lance J Twyman
Journal:  ACS Appl Mater Interfaces       Date:  2019-11-19       Impact factor: 9.229

Review 3.  Dendrimers as Antiamyloid Agents.

Authors:  Svetlana A Sorokina; Zinaida B Shifrina
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

Review 4.  Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview.

Authors:  Abdullah K Alshememry; Nasser B Alsaleh; Nora Alkhudair; Rami Alzhrani; Aws Alshamsan
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.